Physician
Pathology
Dr. Catherine M. Spier, MD
|
|
Give Review
Catherine Spier practices Pathology. She attended University of North Dakota School of Medicine and Health Sciences. Catherine Spier is a published doctor and has 68 publications published. The lastest was: 'Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma.' Catherine Spier accepts Medicare payments and is listed with Medicare.gov.
Publications
- Assessment of carbonic anhydrase IX expression and extracellular pH in B-cell lymphoma cell line models.
- Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high risk limited stage aggressive B-cell lymphoma: SWOG S0313.
- Phase II study of imexon, a pro-oxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma.
- Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma.
- A Comparative Analysis of Prognostic Factor Models for Follicular Lymphoma Based on a Phase III Trial of CHOP-Rituximab versus CHOP + 131Iodine--Tositumomab.
- Phase III Randomized Intergroup Trial of CHOP Plus Rituximab Compared With CHOP Chemotherapy Plus 131Iodine-Tositumomab for Previously Untreated Follicular Non-Hodgkin...
- Alisertib (MLN8237) an investigational agent suppresses Aurora A and B activity, inhibits proliferation, promotes endo-reduplication and induces apoptosis in T-NHL cel...
- Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0...
- Diffuse aggressive histologies of non-hodgkin lymphoma: treatment and biology of limited disease.
- Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless...
- Predominance of chromosome 5 deletions in myeloid neoplasia associated with solid tumors managed by surgical excision.
- Mast cell growth factor (c-kit ligand) restores growth of multipotent progenitors in myelodysplastic syndrome.
- Malignant lymphoma with primary presentation in the spleen. A study of 20 patients.
- Immunotherapy of advanced malignancy by direct gene transfer of an interleukin-2 DNA/DMRIE/DOPE lipid complex: phase I/II experience.
- Myelodysplastic transformation of polycythemia vera: case report and review of the literature.
- Cutaneous myiasis. Immunohistologic and ultrastructural morphometric features of a human botfly lesion.
- Altered expression of P-glycoprotein and cellular adhesion molecules on human multi-drug-resistant tumor cells does not affect their susceptibility to NK- and LAK-medi...
- Antigen-driven oligoclonal expansion of tumor-infiltrating B cells in infiltrating ductal carcinoma of the breast.
- Immunologic approaches to the classification of non-Hodgkin''s lymphomas.
- Lethal midline granuloma with a novel T-cell phenotype as found in peripheral T-cell lymphoma.
- Clonal ambiguity of human immunodeficiency virus-associated lymphomas. Similarity to posttransplant lymphomas.
- Mantle zone lymphoma with central nervous system involvement.
- Immunotopographic assessment of lymphoid and plasma cell malignancies in the bone marrow.
- Immunotyping malignant lymphomas. A boon to diagnosis.
- Expression of the EVI1 gene in chronic myelogenous leukemia in blast crisis.
- Histopathology and immunophenotype of the spleen during acute antibody-mediated rejection.
- Pre-B cell acute lymphoblastic leukemia in the newborn.
- Isolated ocular involvement in non-Hodgkin's lymphoma with immunocytochemical evaluation.
- Optimization of immunocytochemical P-glycoprotein assessment in multidrug-resistant plasma cell myeloma using three antibodies.
- Burkitt's-like lymphoma of T-cell type.
- Differentiation of chronic lymphocytic leukemia from other "well to intermediate differentiated" lymphoproliferative disorders by the mouse rosette assay.
- Generation of cytotoxic effector cells against human melanoma.
- Gene Expression and Serum Cytokine Profiling of Low Stage CLL Identify WNT/PCP, Flt-3L/Flt-3 and CXCL9/CXCR3 as Regulators of Cell Proliferation, Survival and Migration.
- T-cell antigen-positive multiple myeloma.
- Immunophenotypes in "well-differentiated" lymphoproliferative disorders, with emphasis on small lymphocytic lymphoma.
- Lymphomas of the mediastinum.
- Nuclear contour irregularity correlates with Leu-9-, Leu-8- cells in benign lymphoid infiltrates of skin. An ultrastructural morphometric and quantitative immunophenot...
- A multidisciplinary approach to the diagnosis of cutaneous T-cell lymphomas.
- Immunologic complexity of lymphoblastic lymphoma.
- NCAM (CD56)-positive malignant lymphoma.
- The presence of bcl-1 and bcl-2 gene rearrangements in diffuse small cleaved-cell lymphoma. A disease with diverse molecular and immunophenotypic findings.
- Expression of the multidrug resistance gene product (P-glycoprotein) in myelodysplasia is associated with a stem cell phenotype.
- Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19).
- Delineation of a novel pre-B cell component in plasma cell myeloma: immunochemical, immunophenotypic, genotypic, cytologic, cell culture, and kinetic features.
- Myelomonocytic myeloma cell line (LB 84-1).
- Immunophenotyping in the management of gastric lymphoma.
- Myelomonocytic antigen positive multiple myeloma.
- Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia.
- P-glycoprotein expression in human plasma cell myeloma: correlation with prior chemotherapy.
- Neural cell adhesion molecule-positive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement.
- Lennert's lymphoma. A clinicopathologic study with emphasis on phenotype and its relationship to survival.
- HLA-DR (Ia) immune phenotype predicts outcome for patients with diffuse large cell lymphoma.
- Prognostic significance of the Ki-67-associated proliferative antigen in aggressive non-Hodgkin's lymphomas: a prospective Southwest Oncology Group trial.
- P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil.
- The aberrancy of immunophenotype and immunoglobulin status as indicators of prognosis in B cell diffuse large cell lymphoma.
- Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetence.
- Tumor-infiltrating T-lymphocytes in B-cell diffuse large cell lymphoma related to disease course.
- Transcript profiling in peripheral T-cell lymphoma, not otherwise specified, and diffuse large B-cell lymphoma identifies distinct tumor profile signatures.
- Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma.
- Phase I/II study of the P-glycoprotein modulator PSC 833 in patients with acute myeloid leukemia.
- Diffuse small cleaved-cell lymphoma: a heterogeneous disease with distinct immunobiologic subsets.
- The Burkitt-like lymphomas: a Southwest Oncology Group study delineating phenotypic, genotypic, and clinical features.
- Immunobiologic factors predictive of clinical outcome in diffuse large-cell lymphoma.
- Independent prognostic significance of a nuclear proliferation antigen in diffuse large cell lymphomas as determined by the monoclonal antibody Ki-67.
- The prognostic significance of the immunotype in diffuse large-cell lymphoma: a comparative study of the T-cell and B-cell phenotype.
- Successful renal transplant outcome after intravenous gamma-globulin treatment of a highly sensitized pediatric recipient.
- Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Gr...
Schools
Univ Of Nd Sch Of Med and Hlth Sci
Doctors Specialties
- Pathology
Accepted Insurances
Education
-
University of North Dakota School of Medicine and Health Sciences
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1164594446 |
| Last Name Of The Provider | SPIER |
| First Name Of The Provider | CATHERINE |
| View All |
Similar Doctors
|
|
Dr. Osama M. Abdelatif, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maria A. Proytcheva, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. George E. Wilcox II, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brad E. Wheeler, MD
This Doctor is OpenDoctor Recommended.
|